Cluster composition

Functions

CategoryNameIntersectionWithQueryPValueGenesInTermGenesInQueryGenesInTermInQueryID
GeneOntologyCellularComponentSchmidt-Lanterman incisure

MPDZ PARD3

2.85e-0417312GO:0043220
GeneOntologyCellularComponentcompact myelin

MPDZ PARD3

4.39e-0421312GO:0043218
GeneOntologyCellularComponentPML body

HIPK3 RNF6 EIF3E

8.30e-04125313GO:0016605
GeneOntologyCellularComponentbicellular tight junction

APC MPDZ PARD3

9.51e-04131313GO:0005923
GeneOntologyCellularComponenttight junction

APC MPDZ PARD3

1.13e-03139313GO:0070160
GeneOntologyCellularComponentapical junction complex

APC MPDZ PARD3

1.63e-03158313GO:0043296
GeneOntologyCellularComponentaxonal growth cone

APC PARD3

2.03e-0345312GO:0044295
GeneOntologyCellularComponentextracellular matrix

ENAM CPA3 HPSE2 RELN ADAMTS8

2.59e-03656315GO:0031012
GeneOntologyCellularComponentexternal encapsulating structure

ENAM CPA3 HPSE2 RELN ADAMTS8

2.62e-03658315GO:0030312
DomainCadherin_tail

PCDHGB6 PCDHGA11

1.82e-0337322PF15974
DomainCadherin_CBD

PCDHGB6 PCDHGA11

1.82e-0337322IPR031904
DomainCadherin_C_2

PCDHGB6 PCDHGA11

2.35e-0342322PF16492
DomainCadherin_C

PCDHGB6 PCDHGA11

2.35e-0342322IPR032455
Domainzf-RING_2

SCAF11 RNF6

3.57e-0352322PF13639
DomainCadherin_N

PCDHGB6 PCDHGA11

5.53e-0365322IPR013164
DomainCadherin_2

PCDHGB6 PCDHGA11

5.53e-0365322PF08266
Pubmed

Histone methyltransferase SETD2 modulates alternative splicing to inhibit intestinal tumorigenesis.

APC SETD2

8.20e-07232228825595
Pubmed

An antibody-based proximity labeling map reveals mechanisms of SARS-CoV-2 inhibition of antiviral immunity.

APC MPDZ SETD2 TMEM131 WDHD1 TTLL4 EIF3E

3.82e-0673332734672954
Pubmed

Construction of long-transcript enriched cDNA libraries from submicrogram amounts of total RNAs by a universal PCR amplification method.

TRPM6 APC TMEM131 PARD3 WDHD1 GEN1 TTLL4 HPS1

4.69e-06108432811544199
Pubmed

Genetic targeting of principal neurons in neocortex and hippocampus of NEX-Cre mice.

APC RELN

1.72e-05732217146780
Pubmed

Distinct gene loci control the host response to influenza H1N1 virus infection in a time-dependent manner.

RNF6 HPS1

2.29e-05832222905720
Pubmed

Reelin sets the pace of neocortical neurogenesis.

RELN PARD3

3.67e-051032222069190
Pubmed

Selective dopamine D2 receptor deletion from Nkx6.2 expressing cells causes impaired cognitive, motivation and anxiety phenotypes in mice.

APC RELN

4.49e-051132237945756
Pubmed

The RNA-mediated estrogen receptor α interactome of hormone-dependent human breast cancer cell nuclei.

RBM7 APC MPDZ SETD2 SCAF11 PARD3 TEX10 EIF3E

4.82e-05149732831527615
Pubmed

Large-scale characterization of HeLa cell nuclear phosphoproteins.

RBM7 SETD2 SCAF11 PARD3 WDHD1 USP42

6.59e-0577432615302935
Pubmed

Mutant p53 interactome identifies nardilysin as a p53R273H-specific binding partner that promotes invasion.

MPDZ PARD3

7.41e-051432222653443
Pubmed

Pals1 is a major regulator of the epithelial-like polarization and the extension of the myelin sheath in peripheral nerves.

MPDZ PARD3

8.55e-051532220237282
Pubmed

Lgl1 deficiency disrupts hippocampal development and impairs cognitive performance in mice.

RELN PARD3

9.76e-051632231415124
Pubmed

A Rich1/Amot complex regulates the Cdc42 GTPase and apical-polarity proteins in epithelial cells.

MPDZ PARD3

1.11e-041732216678097
Pubmed

Fat1 interacts with Fat4 to regulate neural tube closure, neural progenitor proliferation and apical constriction during mouse brain development.

MPDZ PARD3

1.24e-041832226209645
Pubmed

Gli3 is required for the specification and differentiation of preplate neurons.

RELN PARD3

1.39e-041932216168404
Pubmed

MARCKS modulates radial progenitor placement, proliferation and organization in the developing cerebral cortex.

RELN PARD3

1.39e-041932219666823
Pubmed

Cell Metabolic Alterations due to Mcph1 Mutation in Microcephaly.

APC PARD3

1.54e-042032232294449
Pubmed

The role of α-E-catenin in cerebral cortex development: radial glia specific effect on neuronal migration.

RELN PARD3

1.54e-042032225147501
Pubmed

Crumbs 2 prevents cortical abnormalities in mouse dorsal telencephalon.

RELN PARD3

1.54e-042032226802325
Pubmed

AMP-activated protein kinase phosphorylates retinoblastoma protein to control mammalian brain development.

APC PARD3

1.70e-042132219217427
Pubmed

MPP3 is required for maintenance of the apical junctional complex, neuronal migration, and stratification in the developing cortex.

MPDZ PARD3

1.87e-042232223658188
Pubmed

Loss of CRB2 in the mouse retina mimics human retinitis pigmentosa due to mutations in the CRB1 gene.

MPDZ PARD3

2.84e-042732223001562
Pubmed

Genome-wide association study of peripheral neuropathy with D-drug-containing regimens in AIDS Clinical Trials Group protocol 384.

HPSE2 WDHD1

3.51e-043032224554482
Pubmed

DNA sequence and analysis of human chromosome 9.

TRPM6 MPDZ DBH TEX10

3.58e-0437032415164053
Pubmed

Onset of Spinal Cord Astrocyte Precursor Emigration from the Ventricular Zone Involves the Zeb1 Transcription Factor.

APC RELN

4.00e-043232227806288
Pubmed

MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons.

RBM7 APC SETD2 RELN TEX10 USP42

4.05e-04108232638697112
Pubmed

Loss of Usp9x disrupts cell adhesion, and components of the Wnt and Notch signaling pathways in neural progenitors.

APC PARD3

4.79e-043532228808228
Pubmed

Paralog knockout profiling identifies DUSP4 and DUSP6 as a digenic dependence in MAPK pathway-driven cancers.

TRPM6 HIPK3 APC PLCZ1 ADAMTS8

5.06e-0473032534857952
Pubmed

A SMAD1/5-YAP signalling module drives radial glia self-amplification and growth of the developing cerebral cortex.

APC RELN

5.65e-043832232541003
Pubmed

The apical complex protein Pals1 is required to maintain cerebellar progenitor cells in a proliferative state.

RELN PARD3

6.26e-044032226657772
InteractionSLC35G1 interactions

APC SETD2 WDHD1

2.10e-0534323int:SLC35G1
Cytoband5q31

PCDHGB6 PCDHGA11

2.94e-031153225q31
CytobandEnsembl 112 genes in cytogenetic band chr10q24

HPSE2 HPS1

7.71e-03189322chr10q24
GeneFamilyClustered protocadherins

PCDHGB6 PCDHGA11

2.72e-036422220
GeneFamilyRing finger proteins

TRIM54 SCAF11 RNF6

4.33e-0327522358
GeneFamilyPDZ domain containing

MPDZ PARD3

1.45e-021522221220
GeneFamilyArmadillo repeat containing|Protein phosphatase 1 regulatory subunits

APC PARD3

2.02e-02181222694
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRIM54 CLEC4E CPA3 GLT1D1 TESPA1

1.31e-071693252e15a9317da4017757d184f7cc91bd66b072ac51
ToppCellrenal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Immune-Myeloid-Granulocytic|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group

CLEC4E CPA3 GLT1D1 TESPA1

6.98e-061733249eaec30f9a3655b53ece1b66848201a7f85bbdf5
ToppCellrenal_cortex_nuclei-Adult_normal_reference-Immune-Myeloid-Granulocytic|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group

CLEC4E CPA3 GLT1D1 TESPA1

7.81e-06178324af9bcee71fb44a6342d4b92bba5b8ddfeeaa24b2
ToppCelldroplet-Marrow-nan-3m|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

APC SETD2 SCAF11 FILIP1L

8.90e-061843241154a5ad7b8512272b7476f949ddac350910bfb7
ToppCellfacs-Lung-EPCAM-24m-Hematologic-Proliferating_Immune|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC4E CPA3 WDHD1 TESPA1

9.29e-061863249ce3bd121869215a4e6114a310f9d2fb5adaef61
ToppCellfacs-Lung-EPCAM-24m-Hematologic|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC4E CPA3 WDHD1 TESPA1

9.29e-0618632418c40203463d4dd8558c04977d52e400a8268f90
ToppCellfacs-Lung-EPCAM-24m-Hematologic-leukocyte|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC4E CPA3 WDHD1 TESPA1

9.29e-06186324a7fd35eabcfb534019dfe5a8a600bf2ec47c1ac2
ToppCellfacs-Lung-24m-Hematologic-myeloid-leukocyte-proliferating_myeloid_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLEC4E CPA3 WDHD1 TESPA1

9.69e-06188324797ce39602f0f78081eb44a21da0d9443f7fd9cf
ToppCellfacs-Lung-24m-Hematologic-myeloid-leukocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLEC4E CPA3 WDHD1 TESPA1

9.69e-0618832461b6047affa18c5e71210fcce449e2bbe7cf141b
ToppCellBrain_organoid-organoid_Paulsen_bioRxiv-1_mon-Proliferating-Cycling_Progenitors|1_mon / Sample Type, Dataset, Time_group, and Cell type.

MPDZ TMEM131 PARD3 USP42

1.21e-05199324358c4b3037f59378db8916a2fbe9ed4830cf1449
ToppCellPBMC-Severe-Myeloid-Neutrophil-Neutrophil-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.09)

TRPM6 CLEC4E CPA3

1.34e-04139323fa0eedebf53317928022c3bed391ce99a2114f98
ToppCellCOVID-19-Mast_cells-Transitioning_MDM|COVID-19 / group, cell type (main and fine annotations)

TRPM6 CPA3 GLT1D1

1.52e-041453235c5fed4620c4c312d1052b8acad910453f7e8fcc
ToppCellrenal_medulla_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic-Mast_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

TRIM54 CPA3 TESPA1

1.71e-04151323f5ae450e3daa10540ca8437d05efe2d86ac70960
ToppCellfacs-Trachea-nan-24m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC4E CPA3 TESPA1

1.71e-0415132326fd55efb647c41436416d45952ee97b050e632c
ToppCellfacs-Trachea-24m-Hematologic-myeloid-granulocyte|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLEC4E CPA3 TESPA1

1.92e-04157323188d2f85babcd4eefe20e7a392d851b2e1185bab
ToppCellCOVID_non-vent-Myeloid-Monocytic-SC_&_Eosinophil|COVID_non-vent / Disease condition, Lineage, Cell class and subclass

TRPM6 MPDZ CPA3

1.96e-041583230d4fe87fc7901dd5f9c004e91708a03cafdb4ad9
ToppCellfacs-Trachea-18m-Hematologic-myeloid-granulocyte|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype

CLEC4E CPA3 TESPA1

2.07e-04161323d1f2e5245c7c247b684f48f9f877e149a3ee7c06
ToppCellASK428-Immune-Mast_cell|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq

CPA3 TESPA1 EIF3E

2.14e-04163323569ca0e8ce307f258910b0c75c498009a9651e6e
ToppCellrenal_cortex_nuclei-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLEC4E CPA3 GLT1D1

2.18e-041643232c929996a19bbe29949010928001c277b5494a42
ToppCellfacs-Heart-LA-18m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 CLEC4E DBH

2.22e-0416532395866f7cc6eb1bb51a034a104a0eb2a53b0256f2
ToppCellMild-Myeloid-Mast-|Mild / Condition, Lineage, Cell class and cell subclass

TRIM54 CPA3 TESPA1

2.22e-0416532393d3909a0f5f43d473d5005c842d7d73e25eceed
ToppCellfacs-Heart-LA-18m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 CLEC4E DBH

2.22e-04165323f8bfe336b9a4460b9349c01acd0bd3167812662f
ToppCellnucseq-Immune-Hematopoietic-Granulocytic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CPA3 HPSE2 TESPA1

2.22e-0416532337615622c736e43260c38016e7c9e565ac97a3e8
ToppCell10x5'-lymph-node_spleen-Myeloid_Mac-Intermediate_macrophages|lymph-node_spleen / Manually curated celltypes from each tissue

MPDZ CLEC4E GLT1D1

2.22e-04165323c3fa9225d2f9c9e821d4fbd2315fcc98ce1f1c55
ToppCellMild-Myeloid-Mast|Mild / Condition, Lineage, Cell class and cell subclass

TRIM54 CPA3 TESPA1

2.22e-041653235fa9552c37890c5cc7e672a47038aebba2413cb4
ToppCellnucseq-Immune-Hematopoietic-Granulocytic-Mast/Basophil|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CPA3 HPSE2 TESPA1

2.22e-04165323640bb71e74a61df2fcb01ceeabe4c493ef836b21
ToppCellnucseq-Immune-Hematopoietic|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2

CPA3 HPSE2 TESPA1

2.22e-04165323f3df74b5763130c71c0a482a3a23f6b22acc2892
ToppCellfacs-Trachea-nan-18m-Myeloid-granulocyte|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation

CLEC4E CPA3 TESPA1

2.26e-041663237f8b4cf63c3e292ae421f111edaa4572717f4db1
ToppCellhealthy_donor-Myeloid-Monocytic-Neutrophil|healthy_donor / Disease condition, Lineage, Cell class and subclass

TRPM6 CLEC4E GLT1D1

2.34e-0416832304259f5a9b067cd1b5619e34591e4b2fccc18535
ToppCellASK428-Immune-Mast_cell|Immune / Donor, Lineage and Cell class of Lung cells from Dropseq

CPA3 TESPA1 EIF3E

2.34e-04168323c399fcb4d1d0be48026c2ecabc34a5935e7adf73
ToppCellControl-Mast_cells|Control / group, cell type (main and fine annotations)

CPA3 HPSE2 TESPA1

2.38e-04169323fdb9abca1d0f4fdc32dd8ac6231651ef34aa5afb
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 DBH ADAMTS8

2.43e-04170323615cf9639c66b3fbd984ebe3f345280005d3c38a
ToppCelldroplet-Heart-HEART_(ALL_4:4:4:1:1)-30m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 DBH ADAMTS8

2.43e-04170323d99f61aa85ea3f775165cb433421e6f1cda4f96b
ToppCellControl-Mast_cells-Mast_cells|Control / group, cell type (main and fine annotations)

CPA3 HPSE2 TESPA1

2.43e-04170323c80f6d29096c372da95a8407f402349ff1bb7018
ToppCellfacs-Heart-Unknown-3m-Mesenchymal-atrial_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 DBH ADAMTS8

2.51e-04172323bd468a7ea6ec832dcf6a816a1e0c03fa0f176dad
ToppCellfacs-Heart-Unknown-3m-Mesenchymal-atrial_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 DBH ADAMTS8

2.51e-04172323ee8ce9e8c9a6d3ee2be113f77743958005f4b3f0
ToppCellPrimary_Motor_Cortex_(M1)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HPSE2 RELN PARD3

2.55e-04173323af85fb9f6e26a044ca4d23e5872039b1a7b73b1b
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2-Exc_L3-4_RORB_SEMA6D|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

TRIM54 TESPA1 FILIP1L

2.55e-041733239a2d42f8d9cb834856522661d524abb91c4637c5
ToppCell10x_3'_v2v3-Non-neoplastic-Myeloid-Mast-Mast-G|10x_3'_v2v3 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group

TRIM54 CPA3 TESPA1

2.55e-041733233a39c7f290a9914fcf747e6bc6f13a509413b33c
ToppCellprimary_auditory_cortex_(A1C)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

CLEC4E HPSE2 RELN

2.55e-041733230ba64e5385fe714f876002520f8b5202809bf11e
ToppCellfacs-Marrow-B-cells-18m-Lymphocytic-early_pro_B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM131 PCDHGB6 PCDHGA11

2.60e-041743234cdf2eedc28d88d18241ee390092426fdf849e79
ToppCellfacs-Marrow-B-cells-18m-Lymphocytic-early_pro-B_cell|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TMEM131 PCDHGB6 PCDHGA11

2.60e-04174323268be5e7d2a18b866770b7cdb966c3958c7e6534
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRIM54 HPSE2 DBH

2.73e-04177323c9b02a2e1ff2aa18c37e88a53b06a5b696a442ae
ToppCellPND03-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC-ASMC_mature|PND03 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

TRIM54 HPSE2 DBH

2.73e-041773237ebdcedfe02da6d05bba3d625d8bd4c4ea96e4ad
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-pericyte_cell-Pericytes-Pericytes_L.2.3.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

DBH ADAMTS8 FILIP1L

2.73e-04177323452ec2df36c6d656a7cdadc55be545ccdb146a29
ToppCellMid-temporal_gyrus_(MTG)-Neuronal-Inh_GABAergic-i_Gaba_2-GABA_VIP_1-Inh_L1_SST_CXCL14|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types

HPSE2 RELN PARD3

2.87e-04180323b6efdb4d319ef6f87f559acd974e5a71b06a2322
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.11e-041853237b1c5d99bd7a6e148524029758cee244a17f5d09
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HPSE2 ADAMTS8 FILIP1L

3.11e-04185323e58a009aaf342be019a909747b1895d5987d4daf
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.11e-04185323e9033a03d574956cf3ae228740b3166e40a6397f
ToppCellsystemic_lupus_erythematosus-managed-Hematopoietic-Progen-male|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.11e-04185323a139e95d31af9866ed2d4618ad67557851b98ef3
ToppCell3'-Distal_airway-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.11e-04185323578f12c6b2e33d09598dc8e022a20c8555d1325c
ToppCellSmart-seq2-bone_marrow_(Smart-seq2)-hematologic-hematopoietic_progenitor-hematopoietic_stem_cell|bone_marrow_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CPA3 TESPA1 EIF3E

3.16e-04186323aefb9c186254ba7b02a5ae2bcea7bff2574178f7
ToppCellTCGA-Pancreas-Primary_Tumor-Pancreatic_Adenocarcinoma-Ductal_Adenocarcinoma-1|TCGA-Pancreas / Sample_Type by Project: Shred V9

APC SCAF11 TMEM131

3.16e-0418632303db813598b67b1e08f759758a1c2023396921fa
ToppCell3'-Parenchyma_lung-Endothelial-Lymphatic_EC-endothelial_cell_of_lymphatic_vessel-Lymphatic_EC_differentiating|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

MPDZ RELN FILIP1L

3.16e-0418632320340a5b5cc7f07386498a4ef937d6fbc9e347c4
ToppCellFetal_29-31_weeks-Mesenchymal-airway_smooth_muscle_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor

HPSE2 ADAMTS8 FILIP1L

3.26e-041883234d1e5f85342ae550086609d7680e32730b78b5d2
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

CLEC4E CPA3 GLT1D1

3.26e-0418832336ff615154d6d9e3ba6ccb73a0f11574bcbf5ece
ToppCell-Unknown-Endothelial-Myofibroblast| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HPSE2 TEX10 TTLL4

3.26e-041883236468fa95ad0395395301115286f2d8c0df5d3882
ToppCellsystemic_lupus_erythematosus-flare-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.26e-0418832388b808561ebde997ac8a8bbd1d9bbda49bbb6646
ToppCell-Unknown-Endothelial| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HPSE2 TEX10 TTLL4

3.26e-041883237a81ac5c79c3eb26639b52d2b9fd5e7ef9798fd6
ToppCellwk_15-18-Hematologic-Myeloid-Basophil|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

TRPM6 CPA3 TESPA1

3.26e-041883233638d85452de15a060146628fbbad9d2a36feb13
ToppCell-Unknown| / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2

HPSE2 TEX10 TTLL4

3.26e-041883239cb718bfe1358c6fd842f096e228eb0abb9aefc6
ToppCellnormal_Lung-Fibroblasts-Smooth_muscle_cells|normal_Lung / Location, Cell class and cell subclass

HPSE2 ADAMTS8 FILIP1L

3.26e-04188323fd70fb89570f014d1299c60fe017dc09f24e57c6
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic-myofibroblast_(RSPO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HPSE2 ADAMTS8 FILIP1L

3.26e-04188323879de94924de978478696fc7838e05a4d795b905
ToppCell5'-Adult-SmallIntestine-Mesenchymal-myocytic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

HPSE2 ADAMTS8 FILIP1L

3.31e-04189323ab7ece0a517499b70b7754720d3e434765363af6
ToppCellnormal_Lung-MAST_cells-MAST|normal_Lung / Location, Cell class and cell subclass

CPA3 TESPA1 EIF3E

3.31e-04189323fd053209034fca6eaefe0e5ad024ac4548a100c9
ToppCell10x_3'_v3-lymph_node_(10x_3'_v3)-myeloid-myeloid_granulocytic-neutrophil|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type

TRPM6 CLEC4E GLT1D1

3.31e-04189323235c24eeab5139f5821fccd5c879d8787682f4ef
ToppCellnormal_Lung-MAST_cells|normal_Lung / Location, Cell class and cell subclass

CPA3 TESPA1 EIF3E

3.31e-04189323f09e387dc0626536050cd537dda212471a7267c4
ToppCellBALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k)

SETD2 USP42 TESPA1

3.36e-0419032391ba66d4b56c59523485b17738e93f14bb00afa4
ToppCellMesenchymal-airway_smooth_muscle_cell|World / Lineage, Cell type, age group and donor

HPSE2 ADAMTS8 FILIP1L

3.36e-04190323645e56b02edc3702c7db917b8ecd5eed0decaf71
ToppCellmetastatic_Brain-MAST_cells|metastatic_Brain / Location, Cell class and cell subclass

CPA3 TESPA1 EIF3E

3.36e-04190323587bdf020ef222b5b76f0fae0cec3d44bcdac8e6
ToppCellmetastatic_Brain-MAST_cells-MAST|metastatic_Brain / Location, Cell class and cell subclass

CPA3 TESPA1 EIF3E

3.36e-041903239dc8afb99de9e4d41f26a41cd8cf1fc0100a54f0
ToppCellPCW_10-12-Hematologic_ErythroMegGranulo-Hem_Granulocytic-im_mast/basophil_(18)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung

ENAM CPA3 TESPA1

3.41e-0419132347f20686001f945bc31d5a0b974958e4009edb34
ToppCellILEUM-inflamed-(8)_Smooth_muscle_cells|inflamed / shred on tissue, inflammation_status, cell class(v3), cell subclass (v2)

HPSE2 ADAMTS8 FILIP1L

3.52e-04193323084c88f08ce0ecd6c9f4334caed370eb2154f896
ToppCelldroplet-Limb_Muscle-nan-24m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 ADAMTS8 FILIP1L

3.57e-04194323fb234d97191c95b7880280c6e4ed5df124ffb0e1
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.57e-0419432391205b22650e7ecdb72bb59348ce2530b76c532c
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.57e-041943238fae8061b350336299aa81f378e07deadbd55123
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.57e-041943234d7d24390fdb379f943ddcc70a63f23955e10163
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.57e-041943236e12a7da35be4c0ecf998ef94b8989b89d74b200
ToppCell3'-Broncho-tracheal-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.57e-04194323c52f10140c66e8c0566421c3d535d5d92bf595e1
ToppCelldistal-Hematologic-Basophil/Mast_1-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CPA3 TESPA1 EIF3E

3.62e-04195323a2623f4247c356cf92a0b6f9e454d67edde536ae
ToppCelltumor_Lung-Fibroblasts-Smooth_muscle_cells|tumor_Lung / Location, Cell class and cell subclass

HPSE2 ADAMTS8 FILIP1L

3.62e-04195323ea9ff25020c2fcd1bab80e1829af0f4e4777de8b
ToppCelldistal-Hematologic-Basophil/Mast_1-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CPA3 TESPA1 EIF3E

3.62e-041953235aab51a1e6842f2a397926e451133a67467fc614
ToppCellkidney_cells-Hypertensive_with+without-CKD-Immune-Myeloid-Granulocytic|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group

CLEC4E CPA3 GLT1D1

3.62e-04195323391d8e00dd5f988baa6dbda8414d3c020679ea2f
ToppCelldroplet-Limb_Muscle-MUSCLE-30m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation

TRIM54 SCAF11 FILIP1L

3.62e-041953235c86fddd6d0530beecf45ea5ba6b823123847696
ToppCellsystemic_lupus_erythematosus-managed-Hematopoietic|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.68e-04196323a6fcd4f9a39f8e4ff3076735dd615311104dfd1d
ToppCelldistal-2-Hematologic-Basophil/Mast_1|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CPA3 TESPA1 EIF3E

3.68e-04196323ad21706a281f0b105eb3979e3e47fe0cec6c527f
ToppCelldistal-Hematologic-Basophil/Mast_1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CPA3 TESPA1 EIF3E

3.68e-041963233df0f8fce94bd573f9f9dfeb06d5f68202627740
ToppCellsystemic_lupus_erythematosus-managed-Hematopoietic-Progen-female|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.68e-04196323768fce92bcf47734fa6c4a448f1266f34583fb41
ToppCell3'-Adult-LargeIntestine-Hematopoietic-Myeloid|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract

CLEC4E CPA3 GLT1D1

3.68e-0419632323e22dfb9f9aec17b83574295f889e75f46ded50
ToppCellnormal-na-Hematopoietic|normal / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.68e-04196323c2c1c894706428bad5bfc81e9ae0f921ab1286d3
ToppCell3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5

HPSE2 ADAMTS8 FILIP1L

3.73e-0419732316758f181ef07c60aee63072e1da9572c5c85414
ToppCellnormal-na-Hematopoietic-Progen-female|normal / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.73e-041973238c4bda1842ff8bd808517c2aa179ac7596d1923d
ToppCellsystemic_lupus_erythematosus-managed-Hematopoietic-Progen|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.73e-041973234c928a4dde295bf220bcb0b2f30ca4a106b0e511
ToppCelldistal-1-Hematologic-Basophil/Mast_1|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

CPA3 TESPA1 EIF3E

3.73e-04197323e33752427eefeacbbc538e1b35f37194bdabfc40
ToppCellnormal-na-Hematopoietic-Progen|normal / PBMC cell types (v2) per disease, treatment status, and sex

CPA3 TESPA1 EIF3E

3.73e-0419732314de3db0b36412e801472a6c1502686ae7be9faa
ToppCelldistal-3-mesenchymal-Fibromyocyte|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HPSE2 ADAMTS8 FILIP1L

3.79e-04198323dc93886439a378a0c71e99acb8081bfb6b6d467b
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HPSE2 ADAMTS8 FILIP1L

3.79e-0419832363f7d25201613bd3404c28fb936954190bca91d3
ToppCellwk_15-18-Mesenchymal-Myofibro_&_SMC-Late_airway_SMC|wk_15-18 / Celltypes from embryonic and fetal-stage human lung

HPSE2 ADAMTS8 FILIP1L

3.79e-041983232d0c14f8cabab99bc6d7c27685437c78841c7245
ToppCelldistal-mesenchymal-Fibromyocyte-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed)

HPSE2 ADAMTS8 FILIP1L

3.79e-041983239d1d95e7703cfc70a8ad427e400c340dbd205db8
ToppCellE16.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-ASMC|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif

HPSE2 ADAMTS8 FILIP1L

3.79e-04198323a73534b6ca202c277a70a52281d5b97a3e6cb8ef
DrugClemastine fumarate [14976-57-9]; Up 200; 8.6uM; MCF7; HT_HG-U133A

HIPK3 APC MPDZ SETD2

1.22e-041833247443_UP
DrugButacaine [149-16-6]; Down 200; 13uM; MCF7; HT_HG-U133A

HIPK3 PARD3 RNF6 HPS1

1.47e-041923243469_DN
DrugAlprostadil [745-65-3]; Down 200; 11.2uM; MCF7; HT_HG-U133A

HIPK3 APC CLEC4E RNF6

1.49e-041933244179_DN
DrugGraveoline [485-61-0]; Up 200; 14.4uM; PC3; HT_HG-U133A

HIPK3 APC CLEC4E CPA3

1.49e-041933244276_UP
DrugIdoxuridine [54-42-2]; Up 200; 11.2uM; PC3; HT_HG-U133A

HIPK3 APC TTLL4 FILIP1L

1.52e-041943244200_UP
DrugAtractyloside potassium salt [102130-43-8]; Down 200; 5uM; PC3; HT_HG-U133A

CLEC4E TESPA1 TTLL4 HPS1

1.55e-041953243695_DN
DrugBetulin [473-98-3]; Down 200; 9uM; MCF7; HT_HG-U133A

PARD3 RNF6 HPS1 FILIP1L

1.55e-041953243513_DN
DrugErythromycin [114-07-8]; Up 200; 5.4uM; MCF7; HT_HG-U133A

APC PARD3 HPS1 FILIP1L

1.55e-041953245329_UP
Drug5-aza-2′-deoxycytidine; Up 200; 0.1uM; MCF7; HT_HG-U133A_EA

HIPK3 APC RNF6 FILIP1L

1.55e-04195324920_UP
DrugKarakoline [39089-30-0]; Up 200; 10.6uM; MCF7; HT_HG-U133A

HIPK3 APC CLEC4E RNF6

1.55e-041953244763_UP
DrugAlfadolone acetate [23930-37-2]; Down 200; 10.2uM; MCF7; HT_HG-U133A

APC SETD2 WDHD1 HPS1

1.59e-041963246506_DN
DrugPyrithyldione [77-04-3]; Down 200; 24uM; MCF7; HT_HG-U133A

HIPK3 APC RNF6 HPS1

1.59e-041963243482_DN
DrugPractolol [6673-35-4]; Down 200; 15uM; MCF7; HT_HG-U133A

APC RNF6 HPS1 FILIP1L

1.59e-041963243204_DN
DrugPiperidolate hydrochloride [129-77-1]; Down 200; 11.2uM; MCF7; HT_HG-U133A

APC PARD3 RNF6 HPS1

1.59e-041963246772_DN
DrugNovobiocin sodium salt [1476-53-5]; Down 200; 6.4uM; MCF7; HT_HG-U133A

PARD3 RNF6 HPS1 FILIP1L

1.59e-041963244392_DN
Drugdoxycycline; Down 200; 14.4uM; MCF7; HT_HG-U133A_EA

MPDZ WDHD1 RNF6 HPS1

1.59e-041963241113_DN
DrugEthamsylate [2624-44-4]; Down 200; 15.2uM; MCF7; HT_HG-U133A

MPDZ SETD2 PARD3 WDHD1

1.62e-041973247335_DN
DrugSulfaphenazole [526-08-9]; Down 200; 12.8uM; MCF7; HT_HG-U133A

APC CLEC4E TTLL4 HPS1

1.62e-041973245507_DN
DrugTetrahydroxy-1,4-quinone monohydrate [319-89-1]; Down 200; 21uM; MCF7; HT_HG-U133A

APC MPDZ RNF6 HPS1

1.62e-041973243338_DN
DrugGalanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; PC3; HT_HG-U133A

APC TTLL4 HPS1 FILIP1L

1.62e-041973244186_UP
DrugAscorbic acid [50-81-7]; Up 200; 22.4uM; PC3; HT_HG-U133A

HIPK3 CLEC4E TESPA1 HPS1

1.62e-041973246306_UP
DrugCyclopenthiazide [742-20-1]; Up 200; 10.6uM; PC3; HT_HG-U133A

TRPM6 DBH ADAMTS8 HPS1

1.62e-041973244229_UP
DrugMeclofenoxate hydrochloride [3685-84-5]; Up 200; 13.6uM; MCF7; HT_HG-U133A

APC HPSE2 RELN HPS1

1.62e-041973244729_UP
DrugSTOCK1N-35696; Up 200; 15uM; PC3; HT_HG-U133A

SETD2 PARD3 TTLL4 HPS1

1.62e-041973246564_UP
DrugKetotifen fumarate [34580-14-8]; Up 200; 9.4uM; MCF7; HT_HG-U133A

APC RNF6 HPS1 FILIP1L

1.62e-041973247199_UP
DrugStreptozotocin [18883-66-4]; Up 200; 15uM; MCF7; HT_HG-U133A

PARD3 WDHD1 HPS1 FILIP1L

1.62e-041973247193_UP
DrugTrimethadione [127-48-0]; Up 200; 28uM; HL60; HT_HG-U133A

APC MPDZ RELN DBH

1.65e-041983242486_UP
DrugKynurenine, 3-hydroxy (R,S) [2147-61-7]; Up 200; 17.8uM; PC3; HT_HG-U133A

MPDZ RNF6 PCDHGB6 HPS1

1.65e-041983244681_UP
DrugN6-methyladenosine [1867-73-8]; Down 200; 14.2uM; MCF7; HT_HG-U133A

PARD3 RNF6 HPS1 FILIP1L

1.65e-041983242626_DN
DrugKawain [500-64-1]; Down 200; 17.4uM; HL60; HT_HG-U133A

APC RNF6 HPS1 FILIP1L

1.65e-041983242337_DN
DrugPivmecillinam hydrochloride [32887-03-9]; Up 200; 8.4uM; MCF7; HT_HG-U133A

HIPK3 APC RELN TTLL4

1.65e-041983246014_UP
DrugMethyldopa (L,-) [555-30-6]; Down 200; 19uM; MCF7; HT_HG-U133A

APC PARD3 RNF6 TTLL4

1.65e-041983245272_DN
DrugBetahistine mesylate [54856-23-4]; Up 200; 17.2uM; PC3; HT_HG-U133A

HIPK3 APC MPDZ CLEC4E

1.65e-041983246611_UP
DrugSulfachloropyridazine [80-32-0]; Down 200; 14uM; MCF7; HT_HG-U133A

CLEC4E RNF6 TTLL4 HPS1

1.65e-041983243944_DN
DrugMethotrimeprazine maleat salt [7104-38-3]; Down 200; 9uM; PC3; HT_HG-U133A

APC MPDZ PARD3 RNF6

1.65e-041983247399_DN
DrugFluocinonide [356-12-7]; Down 200; 8uM; MCF7; HT_HG-U133A

SETD2 PARD3 RNF6 HPS1

1.65e-041983243839_DN
DrugTinidazole [19387-91-8]; Up 200; 16.2uM; MCF7; HT_HG-U133A

RELN WDHD1 RNF6 HPS1

1.68e-041993243430_UP
DrugTicarcillin sodium [4697-14-7]; Up 200; 9.4uM; MCF7; HT_HG-U133A

ADAMTS8 RNF6 HPS1 FILIP1L

1.68e-041993247185_UP
DrugPhentolamine hydrochloride [73-05-2]; Up 200; 12.6uM; MCF7; HT_HG-U133A

HIPK3 APC CLEC4E TTLL4

1.71e-042003242323_UP
DrugDiflunisal [22494-42-4]; Down 200; 16uM; MCF7; HT_HG-U133A

PARD3 RNF6 TTLL4 HPS1

1.71e-042003241490_DN
DrugMinocycline hydrochloride [13614-98-7]; Up 200; 8uM; MCF7; HT_HG-U133A

TRPM6 HIPK3 APC MPDZ

1.71e-042003247436_UP
DrugOxamniquine [21738-42-1]; Up 200; 14.4uM; PC3; HT_HG-U133A

HIPK3 APC HPSE2 FILIP1L

1.71e-042003244006_UP
DrugN-Q-I

CPA3 DBH

1.72e-0414322CID015942689
DiseaseGastrointestinal Hemorrhage

APC RELN

4.08e-059322C0017181
Diseasecholangiocarcinoma (is_implicated_in)

APC WDHD1

2.60e-0422322DOID:4947 (is_implicated_in)
Diseasecalcium measurement

TRPM6 CPA3 HPSE2 TMEM131 HPS1

5.38e-04628325EFO_0004838
DiseaseInflammatory Bowel Diseases

APC HPS1

6.63e-0435322C0021390
DiseaseAdenocarcinoma of lung (disorder)

TRPM6 APC EIF3E

1.43e-03206323C0152013
Diseaseresponse to reverse transcriptase inhibitor, HIV-1 infection, peripheral neuropathy

HPSE2 WDHD1

1.57e-0354322EFO_0000180, EFO_0003100, GO_0061479
Diseasebody fat percentage

ENAM RELN TEX10 FILIP1L

1.84e-03488324EFO_0007800
Diseasepulse pressure measurement, alcohol drinking

C1orf167 ADAMTS8

2.63e-0370322EFO_0004329, EFO_0005763
Diseasechildhood trauma measurement, alcohol consumption measurement

PCDHGB6 PCDHGA11

2.70e-0371322EFO_0007878, EFO_0007979
DiseaseCorneal astigmatism

ADAMTS8 PARD3

3.17e-0377322EFO_1002040

Protein segments in the cluster

PeptideGeneStartEntry
SSFWQQSNLQSLARR

C1orf167

286

Q5SNV9
RNFCNWQRRFNQPSD

ADAMTS8

291

Q9UP79
NTDWRFSQAQRPGTS

PCDHGA11

816

Q9Y5H2
NTDWRFSQAQRPGTS

PCDHGB6

811

Q9Y5F9
NALRRNPNNSWNSSS

HPSE2

226

Q8WWQ2
NAFSWSNSLQNTNIP

HIPK3

786

Q9H422
NFNRAPSSQNWLTVN

RELN

2521

P78509
NRNFNASWNSIPNTN

CPA3

251

P15088
TTPNAAFNWNTFLQR

GLT1D1

141

Q96MS3
PDRQSSWQFQRSNSN

FILIP1L

1036

Q4L180
SQQFTSVPWNSFNRD

DBH

536

P09172
LNQNSRSEAPNWATQ

EIF3E

426

P60228
QRFNRWNETSCNSSP

GEN1

236

Q17RS7
SPWRNSQQYEVNKSN

ENAM

456

Q9NRM1
RARSSQNIPVQQAWS

HPS1

261

Q92902
QRSNWSTNQCFRNFF

SCAF11

176

Q99590
RWQNRKPLSGNSNSS

SCAF11

1096

Q99590
SLPRDTSNWSNQFQR

PARD3

201

Q8TEW0
TSNWSNQFQRDNARS

PARD3

206

Q8TEW0
FNQSSSSQWRQGTPS

RBM7

181

Q9Y580
TRADSSNFNPQEFWN

PLCZ1

411

Q86YW0
NQTWRAVSRTNPNNG

RNF6

131

Q9Y252
LNSGRQSPSQNERWA

APC

1036

P25054
SNPRQNWNDVTCFLN

CLEC4E

186

Q9ULY5
ANDVFQASNPLWQSR

TRIM54

51

Q9BYV2
NRASPVNASASVQNW

USP42

491

Q9H9J4
NSLWNSRSTNLNRNS

TRPM6

1671

Q9BX84
SELQNTAYSNWNQPR

MPDZ

1136

O75970
SNTATEWSQPRFRNQ

WDHD1

846

O75717
SCNQASQRSWNEFNS

TMEM131

1746

Q92545
NRDRSQSWILSVNPN

TEX10

201

Q9NXF1
SWQQTTFQNRPDSRL

SETD2

1216

Q9BYW2
QSNSEEEQSQSRWPS

TESPA1

491

A2RU30
SSFLNPSFQWNVLNR

TTLL4

361

Q14679